Galmed (GLMD) announced the grant of a new patent related to its lead compound, Aramchol. The patent covers the use of a combination therapy of ...
Machine learning may help identify biomarkers and develop predictive models that could assist in the diagnosis of metabolic ...
A European Medicines Agency committee, on Thursday, accepted the use of an artificial intelligence (AI) tool called AIM-NASH ...
Non-alcoholic fatty liver disease (NAFLD) represents the most common liver disease worldwide affecting approximatively 20–30% ...
The doctor explained that beside alcohol consumption and hepatitis, hypertension can contribute significantly to liver fibrosis.
Harvard Medical School researchers have found that statin use significantly reduces the risk of hepatocellular carcinoma (HCC ...
While the myelofibrosis drug landscape has become more crowded since Syntara (then Pharmaxis) decided to focus on that ...
When mothers eat a diet high in fat and sugars, their unborn babies can develop liver stress that continues into early life.